Page 2 - Best Meningioma doctors: TOP 68 doctors

Prof. Kilic is the first Turkish doctor trained in radiosurgery at Sweden's Karolinska Institute – a pioneer in non-invasive brain tumor treatment.

• Highly specialized in Gamma Knife Radiosurgery for precise, non-surgical tumor targeting
• Holds a neuro-oncology research fellowship from Harvard Medical School and Dana-Farber Cancer Institute
• Member of the International Meningioma Society and World Federation of Neurosurgical Societies
• Former President of the Turkish Nervous System Surgery Society
• Professor and academic leader at Marmara University's Department of Neurosurgery

Heads the European Association of Neurosurgical Societies (EANS) and is recognized as a top global neurosurgeon.

• 37 years of experience of experience in neurosurgery and neuro-oncology.
• Specialist in brain tumor surgery and minimally invasive techniques.
• Expert in neurosurgical procedures with brain mapping.
• Conducts research on novel surgical techniques for brain cancer.
• Awarded the Goldhirsh Foundation Award for innovative neurology treatment.

Professor Keil specializes in advanced imaging techniques for complex interventions, currently leading the Diagnostic and Interventional Radiology Clinic in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided procedures
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for all body regions

Specializes in comprehensive tumor treatment, including cutting-edge immunotherapy and molecular diagnostics at Medical Center in Solingen.

• Board-certified in hematology, oncology, and immunology
• Chief Physician at a certified interdisciplinary cancer center
• Active in molecular biology research for innovative cancer therapies
• Qualified specialist in genetics
• Member of leading oncology societies including American Association for Cancer Research

Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma and leading Oncology at Nordwest Clinic.

• 41 years of experience of experience in oncology and hematology
• Head of Oncology and Hematology at Nordwest Clinic
• Recognized as a top sarcoma specialist

Dr. Dvora Blumental leads the Neuro-oncology Service at Sourasky Medical Center, specializing in meningioma care with 30 years of experience of focused experience.

• Trained at Memorial Sloan-Kettering Cancer Center – one of the world's top cancer hospitals
• Previously directed the Neuro-oncology Service at Huntsman Cancer Institute
• Senior neuro-oncologist since 1998 – vast experience with complex brain tumors
• Fellowship-trained in neuro-oncology at Memorial Sloan-Kettering

Dr. Yildiz specializes in neuroendocrine and rare tumors, with extensive research and clinical experience at Medipol Mega University Hospital.

• Published 17+ papers on neuroendocrine and rare tumors
• Expertise in diagnosing and managing complex tumor cases
• Active member of multiple international medical research studies

Prof. Köstler is a leading expert in targeted cancer therapies with over two decades of experience, specializing in breast and gynecologic malignancies.

• Completed training at the Medical University of Vienna
• Focuses on individualized systemic cancer therapy and immunotherapy
• Deputy Head of the Clinical Division of Oncology
• Published research in biomarker development and tumor biology

Associate Professor Tahsin Ozatli specializes in oncology with extensive experience across multiple cancer types, currently practicing at Istinye Liv University Hospital.

• Specializes in breast, lung, and gastrointestinal cancers
• Internal Medicine Specialist at Malatya State Hospital
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Studied medicine at Selcuk University

Assoc. Prof. Nail Paksoy brings specialized expertise in oncology to Medipol Bahçelievler Hospital, with a focus on targeted therapies.

• Over 15 years of experience of medical oncology fellowship training
• Active participant in international clinical trials for various cancers
• ESMO Board Certified in Medical Oncology
• Published multiple research papers on innovative cancer treatments
• Associate professor at Istanbul Medipol University

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Specialized in Medical Oncology with extensive training at Akdeniz University – Dr. Alemdar brings focused expertise to meningioma cases at Medical Park Antalya.

• Graduated from Kocaeli University Faculty of Medicine
• Completed Medical Oncology specialization in 2018
• Works at Medical Park Antalya Hospital Complex
• 20 years of experience of clinical experience

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Inta Jaunalksne specializes in virotherapy, a cutting-edge immunology approach, with 49 years of experience of experience. She leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute
• Completed internship in Internal Medicine
• Head of Clinical Immunology Center

Dr. Kwan Park is a dedicated neurosurgeon at Samsung Medical Center, specializing in meningioma treatment.

• Expertise in neurosurgical procedures for brain tumors
• Practices at one of South Korea's leading medical centers
• Focuses on personalized treatment plans for each patient

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.